Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 45:293-299, doi:10.1016/j.jacc.2004.09.068
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrabés, J. A.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrabés, J. A.
Right arrow Articles by Soler-Soler, J.

Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia

José A. Barrabés, MD*, David Garcia-Dorado, MD, FACC*,*, Maribel Mirabet, PhD*, Javier Inserte, PhD*, Luis Agulló, PhD*, Bernat Soriano, PharmD{dagger}, Anna Massaguer, PhD{ddagger}, Ferran Padilla, MD*, Rosa-Maria Lidón, MD* and Jordi Soler-Soler, MD, FACC*

* Department of Cardiología, Hospital Universitari Vall d'Hebron, Barcelona, Spain
{dagger} Department of Medicina Nuclear, Hospital Universitari Vall d'Hebron, Barcelona, Spain
{ddagger} Department of Immunology Unit, IDIBAPS, Barcelona, Spain

Manuscript received July 13, 2004; accepted September 28, 2004.

* Reprint requests and correspondence: Dr. David Garcia-Dorado, Servicio de Cardiología, Hospital Vall d'Hebron, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain (Email: dgdorado{at}vhebron.net).

OBJECTIVES: The goal of this study was to assess whether selectin blockade reduces myocardial platelet deposition and platelet-mediated injury after transient ischemia.

BACKGROUND: Selectins participate in platelet adhesion to reperfused endothelium.

METHODS: Thiopental-anesthetized, open-chest pigs were subjected to mechanical injury of the left anterior descending coronary artery followed by a 48-min occlusion and 2 (n = 20) or 4 (n = 16) h of reperfusion. Fifteen minutes before occlusion, animals were blindly allocated to receive a continuous intravenous infusion of the selectin blocker fucoidan (30 µg/kg/min, plus a 1-mg/kg bolus in the latter group) or saline. In isolated rat hearts infused with thrombin-activated platelets, the effects of fucoidan (30 µg/ml) administered during reperfusion after 40 min of global ischemia were also analyzed.

RESULTS: Fucoidan did not prevent the development of cyclic reductions in coronary flow, but reduced the content of 99mTc-labeled platelets in reperfused myocardium after 2 h of reperfusion (23.4 ± 3.3 vs. 42.1 ± 8.3 x 106 platelets/g in treated and untreated animals, p = 0.03) and attenuated the impairment in the coronary flow reserve and reduced infarct size after 4 h (53 ± 2% vs. 73 ± 5% of the ischemic region, respectively, p = 0.003). Treated animals showed a trend toward less neutrophil infiltration early after reperfusion, but not after 4 h. In isolated hearts, fucoidan improved functional recovery and reduced coronary resistance and lactate dehydrogenase release, lacking any beneficial effects if given in the absence of platelets.

CONCLUSIONS: The results suggest that selectin-dependent adhesion is a prominent mechanism of platelet deposition in reperfused cardiac microvessels and highlight its potential as a therapeutic target in patients with acute myocardial infarction.

Abbreviations and Acronyms
  CFR = cyclic flow reduction
  GP = glycoprotein
  LAD = left anterior descending coronary artery
  LDH = lactate dehydrogenase
  LVEDP = left ventricular end-diastolic pressure
  MPO = myeloperoxidase
  VF = ventricular fibrillation




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. L. A. C. Mestriner, F. Spiller, H. J. Laure, F. O. Souto, B. M. Tavares-Murta, J. C. Rosa, A. Basile-Filho, S. H. Ferreira, L. J. Greene, and F. Q. Cunha
Acute-phase protein {alpha}-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism
PNAS, December 4, 2007; 104(49): 19595 - 19600.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Lucchinetti, J. Aguirre, J. Feng, M. Zhu, M. Suter, D. R. Spahn, L. Harter, and M. Zaugg
Molecular Evidence of Late Preconditioning After Sevoflurane Inhalation in Healthy Volunteers
Anesth. Analg., September 1, 2007; 105(3): 629 - 640.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement